NEOPLASMS BY SITE
Clinical trials for NEOPLASMS BY SITE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS BY SITE trials appear
Sign up with your email to follow new studies for NEOPLASMS BY SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for colorectal cancer: experimental drug faces off against standard care
Disease control Recruiting nowThis study tests a new medicine, PF-08634404, combined with standard chemotherapy for people whose colorectal cancer has spread. About 800 adults will be randomly assigned to receive either the new drug or an approved drug (bevacizumab), both with chemo. The goal is to see which …
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 28, 2026 23:50 UTC
-
Could a drug already approved for some cancers help patients with rare genetic tumor types?
Disease control Recruiting nowThis study tests atezolizumab, a drug already approved for certain cancers, in adults and children with rare cancers that have high tumor mutational burden (TMB) or microsatellite instability (MSI). About 30 participants will receive the drug to see if it shrinks tumors or stops …
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Apr 28, 2026 13:01 UTC